• Like
  • 1
  • Favorite

Zomedica Corp. Unveils Breakthrough Veterinary Innovations in New Webinar Series Highlighting Cutting-Edge Diagnostic and Therapeutic Technologies

Reuters05-20

<a href="https://laohu8.com/S/ZOMDF">Zomedica Corp.</a> Unveils Breakthrough Veterinary Innovations in New Webinar Series Highlighting Cutting-Edge Diagnostic and Therapeutic Technologies

Zomedica Corp. has unveiled a series of groundbreaking scientific research results through its new monthly webinar series, aimed at revolutionizing veterinary healthcare. The company, known for its innovative therapeutic and diagnostic solutions for equine and companion animals, is showcasing advancements such as the PulseVet® Shock Wave system, which accelerates healing in musculoskeletal conditions, and the Assisi Loop® and Calmer Canine products for drug-free pain and inflammation management. The TRUFORMA® Diagnostic Platform offers precise, rapid testing for complex veterinary cases, while the TRUVIEW® Digital Cytology System provides automated, high-quality slide preparation for accurate diagnoses. Additionally, the VETGuardian® No-Touch Monitoring System ensures continuous remote tracking of vital signs, and VETIGEL® offers rapid bleeding control. Through these webinars, Zomedica aims to foster a community of forward-thinking professionals and investors, providing insights into its expanding market influence and commitment to advancing animal healthcare.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zomedica Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1029637) on May 19, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • With the tariff war still ongoing, difficult. 
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24